All stock lists
InnovAge Holding Corp. (NASDAQ:INNV)
US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
9.55+0.03 (+0.32%)
Insider Score
––Not scored
INNV Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
INNV analyst forecast
INNV analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
INNV 12-month price target
$13.00+37.6% upsideaverage of 1 firm
$13.00High
$13.00Low
Best analysts covering INNV
- JP Morgan0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
INNV analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Keybanc | Overweight | — | — | Reiterated | 2026-09-09 |
| — | Keybanc | Overweight | — | — | Upgraded | 2026-08-21 |
| KeyBanc | — | $13.00 | +21.3% | — | 2026-08-21 | |
| — | JP Morgan | Underweight | — | — | Reiterated | 2026-02-23 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2024-12-17 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-03-13 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2024-02-08 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2023-02-15 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2023-02-08 |
| — | Goldman Sachs | Neutral | — | — | Reiterated | 2022-11-23 |
| — | Citigroup | Neutral | — | — | Reiterated | 2022-11-16 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2022-09-15 |
| — | Baird | Neutral | — | — | Downgraded | 2022-05-16 |
| — | Piper Sandler | Underweight | — | — | Reiterated | 2022-05-11 |
| — | Piper Sandler | Underweight | — | — | Downgraded | 2022-04-20 |
| — | Goldman Sachs | Neutral | — | — | Downgraded | 2021-12-28 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2021-12-27 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2021-12-17 |
| — | Citigroup | Neutral | — | — | Downgraded | 2021-09-29 |
| — | William Blair | Market Perform | — | — | Downgraded | 2021-09-22 |
| — | Cowen & Co. | Perform | — | — | Reiterated | 2021-09-10 |
| — | Barclays | Overweight | — | — | Upgraded | 2021-08-12 |
| — | Baird | Outperform | — | — | Reiterated | 2021-05-28 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2021-03-29 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2021-03-29 |
| — | Citigroup | Buy | — | — | Reiterated | 2021-03-29 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2021-03-29 |
| — | William Blair | Outperform | — | — | Reiterated | 2021-03-29 |
INNV earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-03 | 0.04 | 0.08 | $228.4M | $239.7M |
| 2026-05-05 | 0.06 | -0.22 | $234.3M | $251.9M |
| 2026-09-08 | 0.07 | 0.06 | $238.3M | $262.0M |
| 2026-11-03 | 0.09 | 0.00 | $257.2M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.